speb/financial-data huggingface dataset:
SURANAT&P.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 376000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 376000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 7744000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 548465000.00
SURANAT&P.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 75923000.00
SURANAT&P.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 50772000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 6125000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 13270000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Share Issued: 135759963.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Special Income Charges: -86940000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 1232186000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 1232186000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: -3546665.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Tax Provision: 15560000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.33
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 6156000.00
SURANAT&P.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -25557000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Total Assets: 1495890000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 1273894000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Total Debt: 122325000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 1376990000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Total Expenses: 209758000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 118900000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 1276031000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 33654000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 87000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 386000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Total Unusual Items: -10715000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: -10715000.00
SURANAT&P.NS balance_sheet (annual, 2023-03-31) — Working Capital: 134612000.00
SURANAT&P.NS income_statement (annual, 2023-03-31) — Write Off: 86701000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — +Operating Expense: 173561000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — +Total Revenue: 252756000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 511000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 44458000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1521431000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 24000000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: 0.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Amortization: 1979000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 1979000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 87044000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 135760000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Basic EPS: 0.59
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 11455000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 75711000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -1200000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 135760000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 13946000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 85456000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 13946000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Change In Inventory: 3380000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 7515000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Change In Payable: -1974000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Change In Receivables: 18442000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: 27363000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 2492000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Common Stock: 135760000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 1338897000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 44558000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Current Assets: 194194000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Current Debt: 8016000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 8016000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 5359000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 16006000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 898000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Depreciation: 91928000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 93907000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 93907000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 91928000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 135760000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Diluted EPS: 0.59
SURANAT&P.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 80568000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — EBIT: 107960000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — EBITDA: 201867000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — End Cash Position: 13947000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -109961000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 8216000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Fixed Assets Revaluation Reserve: 13640000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 145683000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -51617000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 5776000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 44458000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 2128151000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Gross Profit: 208198000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Interest Expense: 7164000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 7164000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Interest Income: 27189000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 27189000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -7805000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 27189000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Inventory: 8216000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 1361455000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -34430000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 87044000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Investments In Other Ventures Under Equity Method: 7000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Investmentsin Associatesat Cost: 212419000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 121083000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 14542000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 14542000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 212426000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 1931357000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 149203000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Net Debt: 8612000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Net Income: 80568000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 80568000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 80567000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 80568000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 80568000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 105634000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 80568000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Net Interest Income: 19382000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 61657000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: -99768000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -99768000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 19382000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Net Other Financing Charges: -2388000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Net PPE: 606720000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: 9445000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 1338897000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 19203000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: -19203000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 4191000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 151575000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Normalized Income: 39927034.80
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 146883000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Operating Income: 34637000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Operating Revenue: 252756000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 135759963.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 45931000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 797000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 3500000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -19384000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: -1000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 87694000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 22626000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Other Payable: 1223000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 44393000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 71510000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Other Special Charges: 8864000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Payables: 1734000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 100000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1539000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Pretax Income: 100796000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -6058000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -1200000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 44558000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 93907000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 344000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 344000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 10132000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 620958000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 67715000.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 10645000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 7132000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 12908000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Share Issued: 135759963.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Special Income Charges: -8864000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 1338897000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 1338897000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 9651034.80
SURANAT&P.NS income_statement (annual, 2024-03-31) — Tax Provision: 20229000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.19
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 0.00
SURANAT&P.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -11900000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Total Assets: 1526608000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 1353439000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Total Debt: 22558000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 1488100000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Total Expenses: 218119000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 38508000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 1332414000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 22502000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 643000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 5359000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 50292000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 50292000.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
SURANAT&P.NS balance_sheet (annual, 2024-03-31) — Working Capital: 178188000.00
SURANAT&P.NS income_statement (annual, 2024-03-31) — Write Off: 0.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 214000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 30338000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 310803000.00
SURANAT&P.NS income_statement (quarterly, 2024-09-30) — Basic Average Shares: 160150000.00
SURANAT&P.NS income_statement (quarterly, 2024-09-30) — Basic EPS: 0.14
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 135760000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 4467000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 198377000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 135760000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 1392592000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 293341000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 4869000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 4869000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 10674000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 1163000.00
SURANAT&P.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 160150000.00
SURANAT&P.NS income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.14
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 11186000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 1466008000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 310803000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 68547000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 68547000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Minority Interest: 146322000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Net Debt: 68949000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 631570000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 1392592000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: -19236000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 135759963.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 53440000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 412000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 193910000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Payables: 4230000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 135759963.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 1392592000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 1392592000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 1606860000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 1461139000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 73416000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 1538914000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 67946000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 1313520000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 57272000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 4016000.00
SURANAT&P.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 282667000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 42119000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 37655000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 135759963.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 0.04
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 17000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 21111000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 21111000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 135759963.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 0.04
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 7584000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — EBIT: 8452000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — EBITDA: 29563000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 37638000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 1522000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 1522000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 2636000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Net Income: 7584000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 7584000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 4947000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 7584000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 7584000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 4947000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: -1522000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: -1522000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 29563000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 7584000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Operating Income: -4481000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 37655000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 12347000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 13433000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 6930000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 17000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 21111000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 1983000.00
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.29
SURANAT&P.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 42136000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — +Operating Expense: 224451000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 92862000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — +Total Revenue: 159209000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 47662000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 2427000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 2427000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 29756000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 29756000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -1405741000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -1405741000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 24000000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 24000000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Amortization: 1960000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 1960000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 78315000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 78315000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 139026590.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 135748592.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Basic EPS: 1.73
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 1.42
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 13947000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 75402000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 75402000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -74803000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 135760000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 135760000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 31323000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 31323000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 208977000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 208977000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 31323000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 31323000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Change In Inventory: 8216000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Change In Other Current Assets: -6797000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Change In Payable: 16372000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Change In Receivables: 14702000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: 32493000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 17376000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Common Stock: 135760000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 135760000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 1563917000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 1563917000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 2804000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 12000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Current Assets: 336887000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 336887000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Current Debt: 18301000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 18301000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 18301000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 18301000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Current Deferred Taxes Liabilities: 561000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Taxes Liabilities: 561000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 37864000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 37864000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 1044000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 1044000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Depreciation: 89787000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 89787000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 87827000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 24495000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Depreciation Income Statement: 87827000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Depreciation Income Statement: 24495000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 139026590.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 135748592.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Diluted EPS: 1.73
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 1.42
SURANAT&P.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 240516000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 192763000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — EBIT: 292941000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — EBIT: 236938000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — EBITDA: 382728000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — EBITDA: 261433000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — End Cash Position: 31322000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 30927000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 0.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 0.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Fixed Assets Revaluation Reserve: 13640000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Fixed Assets Revaluation Reserve: 13640000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: -39757000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Gain Loss On Investment Securities: -289907000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 7306000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 29756000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 29756000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 1890082000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 1890082000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Gross Profit: 156405000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 47650000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Interest Expense: 4765000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 2012000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 4765000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 2012000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Interest Income: 31810000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 31810000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -4765000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 31810000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Inventory: 0.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 0.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 1628202000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 1628202000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -48597000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 78315000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 78315000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Investments In Other Ventures Under Equity Method: 7000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Investments In Other Ventures Under Equity Method: 7000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Investmentsin Associatesat Cost: 209578000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Investmentsin Associatesat Cost: 209578000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Land And Improvements: 113019000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Land And Improvements: 113019000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Long Term Debt: 45984000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 45984000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 45984000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 45984000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Long Term Equity Investment: 209585000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Long Term Equity Investment: 209585000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Machinery Furniture Equipment: 1701661000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Machinery Furniture Equipment: 1701661000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Minority Interest: 143106000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Minority Interest: 143106000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Minority Interests: 6097000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Minority Interests: 580000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Net Debt: 32962000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Net Debt: 32962000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Net Income: 240516000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Net Income: 192763000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Net Income Common Stockholders: 240516000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 192763000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Net Income Continuous Operations: 234419000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 192183000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 240516000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 192763000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 240516000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 192763000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Net Income From Continuing Operations: 287964000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Net Income Including Noncontrolling Interests: 234419000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 192183000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Net Interest Income: -4765000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Net Interest Income: -2012000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Net Investment Purchase And Sale: -46201000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Net Issuance Payments Of Debt: 41727000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Net Long Term Debt Issuance: 41727000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Net Non Operating Interest Income Expense: -4765000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -2012000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Net Other Financing Charges: -6035000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Net Other Investing Changes: -1000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Net PPE: 484341000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Net PPE: 484341000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Net PPE Purchase And Sale: 258841000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Net Tangible Assets: 1563917000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 1563917000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Non Current Deferred Taxes Assets: 18893000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 18893000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Non Current Prepaid Assets: 3259000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Non Current Prepaid Assets: 3259000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Normalized EBITDA: 382728000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 261433000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Normalized Income: 240516000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Normalized Income: 192763000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Operating Cash Flow: 35046000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Operating Income: -68046000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Operating Income: -45212000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Operating Revenue: 159209000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Operating Revenue: 47662000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Ordinary Shares Number: 135759963.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 135759963.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Other Cash Adjustment Outside Changein Cash: -1000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Other Current Assets: -1000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Other Current Assets: -1000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Other Current Liabilities: 5944000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 5944000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Other Equity Interest: 3500000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Other Equity Interest: 3500000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Other Non Cash Items: -27045000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Other Non Current Assets: 1000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 1000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Other Non Operating Income Expenses: 360775000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 284703000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Other Operating Expenses: 104938000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Other Operating Expenses: 61151000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Other Payable: 10531000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Other Payable: 10531000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 81987000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 81987000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Other Short Term Investments: 177654000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 177654000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Other Special Charges: -225943000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Payables: 12958000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Payables: 12958000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 100000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 100000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 0.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 0.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Pretax Income: 288176000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 234926000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -126791000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -74803000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 2804000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 12000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 89787000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 24495000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 317000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 317000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 16168000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 16168000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: 861473000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 861473000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 80590000.00
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 333644000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 3739000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 11045000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Share Issued: 135759963.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 135759963.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Special Income Charges: 225943000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 1563917000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 1563917000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 1563917000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 1563917000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Tax Provision: 53757000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Tax Provision: 42743000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.19
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.18
SURANAT&P.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -58244000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Total Assets: 1798832000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 1798832000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 1609901000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 1609901000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Total Debt: 64285000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 64285000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 1707023000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 1707023000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Total Expenses: 227255000.00
SURANAT&P.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 92874000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 91809000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 91809000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 1461945000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 1461945000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 53945000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 53945000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 764000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Total Tax Payable: 561000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 561000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 281697000.00
SURANAT&P.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 281697000.00
SURANAT&P.NS balance_sheet (annual, 2025-03-31) — Working Capital: 299023000.00
SURANAT&P.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 299023000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — +Operating Expense: 43891000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — +Total Revenue: 41436000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Basic Average Shares: 148777778.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Basic EPS: 0.18
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Depreciation And Amortization In Income Statement: 17873000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Depreciation Income Statement: 17873000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 148777778.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Diluted EPS: 0.18
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 26780000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — EBIT: 31308000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — EBITDA: 49181000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Gross Profit: 41436000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Interest Expense: 1351000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 1351000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Minority Interests: 2292000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Net Income: 26780000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 26780000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 24487000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 26780000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 26780000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 24487000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Net Interest Income: -1351000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -1351000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 49181000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Normalized Income: 26780000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Operating Income: -2455000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Operating Revenue: 41436000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 32750000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Other Operating Expenses: 18760000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Otherunder Preferred Stock Dividend: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Pretax Income: 29957000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 17873000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Tax Provision: 5470000.00
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.18
SURANAT&P.NS income_statement (quarterly, 2025-06-30) — Total Expenses: 43891000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — +Operating Expense: 42107000.00
SURANAT&P.NS income_statement (quarterly, 2025-09-30) — +Total Revenue: 93667000.00